Managing global clinical studies presents many challenges, particularly when the products needed are required in local language packs in one or more of the countries involved in the trial. 

Identifying and securing a reliable supply – and the ability to clear products for use in that country – are essential for a successful study.

In early 2014 a US pharmaceutical company came to Clinigen asking for support in sourcing a number of non-investigational medicinal products (non-IMPs) in several EU markets for local sourcing and delivery direct to the trial sites in those countries.

Using our unmatched regulatory strength, international project management teams and our extensive network of local contacts we were able to identify, source and deliver quality assured product, thereby improving efficiency, visibility, cost and control for the sponsor company.